2021 News

06.03.2021 IR News

Santen to Present Latest Data on Omidenepag Isopropyl at APGC 2021

05.19.2021 Press Release IR News

Santen Announces Medium-Term Plan "MTP2025"

05.19.2021 Press Release IR News

Santen and Glaukos Enter into a New Collaboration in the Development and Commercialization of STN2000100 (DE-128) in the Americas, Australia, and New Zealand

05.18.2021 Press Release IR News

Santen Establishes "Santen Vision for the Earth 2050" Setting Environmental Targets for 2030, Including CO2 Emissions Reduction Targets

05.17.2021 Press Release IR News

Santen expresses a stance to strengthen its gender diversity. -Joining the "30% Club Japan," taking action to increase gender diversity at board and senior management -Becoming a signatory of the "UN Women's Empowerment Principles" promoting gender equality and women's empowerment in the workplace, marketplace and community

05.11.2021 Press Release

Notice of Postponement of "Transition to a Holding Company Structure through Sole-share Transfer and Change in Fiscal Year"

05.11.2021 Press Release IR News

Notice of Board of Director and Corporate Auditor Nominations

05.11.2021 Press Release

Santen Reports Fiscal 2020 Consolidated Performance

05.11.2021 IR News

Santen Reports Fiscal 2020 Consolidated Performance

05.11.2021 IR News

Notice of Postponement of Transition to a Holding Company Structure through Sole-share Transfer and Change in Fiscal Year

04.22.2021 Press Release IR News

Santen has commenced the construction of the new factory in Suzhou to address expanding product demand in China -Toward reinforcing global production and supply structure-

04.09.2021 Press Release

Notice of Recording of Impairment Loss and Revision of Full-Year Earnings Forecasts

04.09.2021 IR News

Notice of Recording of Impairment Loss and Revision of Full-Year Earnings Forecasts

04.06.2021 Information

Santen Presents at a Global Cell Therapy Conference - The Cell & Gene Meeting on the Mediterranean

03.22.2021 Press Release IR News

Notice of Corporate Officer Appointments

03.12.2021 Press Release IR News

Santen Announces Sponsorship of IBSA Blind Football World Grand Prix for the Second Consecutive Year

03.12.2021 Information

Santen Recognized as One of Outstanding Enterprises in 2021 Certified Health and Productivity Management Outstanding Organization (Large Enterprise Category)

02.05.2021 Information

Santen and IAPB Partner to Advocate for Better Eye Health

02.04.2021 Press Release

Santen Reports the 3rd Quarter Fiscal 2020 Consolidated Performance

02.04.2021 Press Release

Notice of Commencement of Preparation for Transition to a Holding Company Structure through Sole-Share Transfer and Change in Fiscal Year

02.04.2021 IR News

(Timely Disclosure) Notice of Commencement of Preparation for Transition to a Holding Company and Change in Fiscal Year

02.04.2021 IR News

Santen Reports the 3rd Quarter Fiscal 2020 Consolidated Performance

02.02.2021 Press Release IR News

Santen and Ube Announces U.S. FDA Acceptance of New Drug Application for STN10117 (DE-117) (JAN: Omidenepag Isopropyl) as a Treatment for Patients with Glaucoma and Ocular Hypertension

02.01.2021 Press Release IR News

Santen and Ube Announces Launch of Glaucoma and Ocular Hypertension Treatment EYBELIS Ophthalmic Solution 0.002% in South Korea

01.08.2021 IR News

Santen to Hold a Presentation for the 39th Annual J.P. Morgan Healthcare Conference

01.08.2021 Information

Corporate Social Responsibility (CSR) page on our website has been updated

01.07.2021 Press Release IR News

Santen Joins the Valuable 500 International Initiative Promoting the Active Participation of People with Disabilities